Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B
Author(s) -
Youwen Tan,
Yun Ye,
Guohong Ge,
Wei Zhao,
Jianhe Gan,
Yun Zhao,
Zhi-Lin Niu,
Dongjun Zhang,
Li Chen,
Yu Xuejun,
Li-Jun Yang
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i7.2089
Subject(s) - lamivudine , medicine , virology , aspartic acid , hepatitis b , hepatitis b virus , methionine , gastroenterology , virus , amino acid , biology , genetics
To investigate the prevalence of nature tyrosine-methionine-aspartic acid-aspartic acid motif mutations in chronic hepatitis B (CHB) patients and to evaluate the efficacy of lamivudine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom